Related Experiment Video
Updated: May 11, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Current understanding of iron overload hazard in patients with myelodysplastic syndrome]
Lu-Xi Song1, Ji-Ying Su, Zhen Zhang
1Department of Hematology, Shanghai Jiaotong University, Shanghai, China.
Abstract:
Patients with myelodysplastic syndromes (MDS) become dependent on blood transfusions and develop into transfusional iron overload, which is exacerbated by increased absorption of dietary iron in response to ineffective erythropoiesis. However, it is uncertain whether there is an association among iron accumulation, clinical complications, and decreased likelihood of survival in MDS patients. Thereby our current understanding of the effects of transfusion dependency and iron overload in MDS are discussed. Particular emphasis should be placed on further characterizing the role of redox-active forms of labile iron and oxidative stress in iron overload, decreased life expectancy and increased risk of leukemic transformation in MDS patients with iron overload.
Insights
Patients with myelodysplastic syndromes (MDS) experience iron overload from blood transfusions, potentially worsening survival and increasing leukemia risk. This review discusses iron
Area of Science:
- Hematology
- Oncology
- Redox Biology
Context:
- Myelodysplastic syndromes (MDS) often lead to transfusion dependency.
- Transfusional iron overload is a common complication in MDS patients.
- Ineffective erythropoiesis exacerbates iron absorption.
Purpose:
- To discuss the effects of transfusion dependency and iron overload in MDS.
- To explore the association between iron accumulation, clinical complications, and survival in MDS.
- To characterize the role of labile iron and oxidative stress in MDS outcomes.
Summary:
- MDS patients receiving transfusions develop iron overload.
- The link between iron overload, complications, and survival in MDS is unclear.
- Redox-active iron and oxidative stress may impact life expectancy and leukemic transformation risk.
Impact:
- Highlights the critical role of iron management in MDS patient care.
- Emphasizes the need for further research into iron's impact on MDS progression.
- Informs clinical strategies for mitigating complications associated with iron overload in MDS.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
04:48Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry (CE-ICP-MS) for Quantification of Iron Redox Species (Fe(II), Fe(III))
Published on: May 4, 2020
Related Concept Videos
The Periodic Table and Organismal Elements
The Periodic Table and Organismal Elements
Periodic Table Provides Information...
Drug Toxicity: Risk factors
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...